Hepatitis Australia, incorporated in 1997, is the peak community organisation to progress national action on issues of importance to people affected by hepatitis B and hepatitis C. Our members are the eight state and territory hepatitis organisations.
An end to hepatitis B and hepatitis C in Australia.
To lead an effective national community response to hepatitis B and hepatitis C in Australia.
Our members are the eight state and territory hepatitis organisations:
- Hepatitis ACT
- Hepatitis NSW
- Hepatitis Queensland
- Hepatitis SA
- Hepatitis Victoria
- Hepatitis WA
- Northern Territory AIDS and Hepatitis Council, and
- Tasmanian Council on AIDS, Hepatitis and Related Diseases.
The way we work:
- We respect Aboriginal and Torres Strait Islander cultures, traditions, views and ways of life.
- We value cultural diversity and promote equality.
- We uphold harm reduction principles.
- We promote the empowerment of hepatitis B and hepatitis C communities.
- We utilise evidence to inform our policies and activities.
- We are ethical, accountable, committed and professional.
The people we work for:
Hepatitis Australia works to improve health and social outcomes for all Australians who are at risk of, or living with hepatitis B or hepatitis C.
We pay particular attention to those groups which are at higher risk of infection or have a disproportionate burden of chronic disease.
Our Strategic Plan 2016 - 2019
You can download a copy of our Strategic Plan by clicking here or on the image below.
Hepatitis Australia Annual Report 2016-2017 - Download a copy
"Elimination is the word that has been on everyone’s lips this year and there are undoubtedly unprecedented opportunities to act decisively to end the hepatitis B and hepatitis C epidemics in Australia by 2030, in line with the World Health Organization’s global targets." CEO and President's Message (p11)
Annual Report 2015-2016 - Download a copy
"During 2015 to 2016 much of our work was associated with advocacy for universal access to the new hepatitis C medications, as well as preparing for the changes to treatment and responding to system issues arising during the first few months of the rollout." - Highlights from 2015-2016 (p12)